Gravar-mail: Reply: Guillain-Barré syndrome, SARS-CoV-2 and molecular mimicry
and Ongoing challenges in unravelling the association between COVID-19
and Guillain-Barré syndrome and Unclear association between COVID-19 and
Guillain-Barré syndrome and Currently available data regarding the
potential association between COVID-19 and Guillain-Barré syndrome